Document is current
Any future updates will be listed below
-
Authors
Kunimasa, Kei https://orcid.org/0000-0002-5241-3486
Sugimoto, Naotoshi
Tamiya, Motohiro
Inoue, Takako
Kawamura, Takahisa
Kanzaki, Ryu
Okami, Jiro
Nishino, Kazumi
- License Information
-
More Information
Article History
Received: 1 May 2022
Accepted: 27 May 2022
First Online: 3 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from the present case.
: Informed consent was obtained from the patient.
: Dr. Kunimasa reports honoraria for lecture from AstraZeneca, Chugai Pharma and Novartis. Dr. Sugimoto reports honoraria for lecture from MSD, Eli Lilly, Chugai Pharma, Taiho Pharmaceutical, Dai-ichi Sankyo and Ono Pharmaceutical. Dr. Tamiya reports grants from Ono Pharmaceutical, Bristol-Myers Squibb, Boehringer Ingelheim and honoraria for lecture from Taiho Pharmaceutical, Eli Lilly, Asahi Kasei Pharmaceutical, MSD, Boehringer Ingelheim, AstraZeneca, Chugai Pharmaceutical, Ono Pharmaceutical, Bristol-Myers Squibb; Dr. Nishino reports a grant from Nippon Boehringer Ingelheim and honoraria for lecture from Chugai Pharma, AstraZeneca, Nippon Boehringer Ingelheim, Eli Lilly Japan, Roche Diagnostics, Novartis, Pfizer Merk and other authors have no conflict of interest.
